Cancer Cancer
Conditions
Interventions
Participants will be randomised into intervention or control groups using minimisation with a 1:1 allocation ratio. Stratification factors will be cancer type (breast, prostate or colorectal) and hosp
Sponsors
University College London
Eligibility
Sex/Gender
All
Age
16 Years to 99 Years
Inclusion criteria
Inclusion criteria: Note, points 1 and 2 are checked by the clinical care team in the initial medical record eligibility screening. 1. Diagnosed with breast, prostate or colorectal cancer within the last 2 and a half years at a participating hospital site 2. Aged 16 years or older 3. Own a smartphone (that uses Android or iOS (Apple) operating systems) 4. Willing and able to provide informed consent 5. Has access to a computer or tablet and an email address, and is willing to complete online questionnaires. 6. Willing to wear an accelerometer for a week at the assessment points
Exclusion criteria
Exclusion criteria: Note, points 1a, 4, 5, 6 and 13 are checked by the clinical care team in the initial medical record eligibility screening. 1. Patients who are more than 2 years post-diagnosis at the point of screening by hospital staff. Due to the potential time gap between screening/inviting participants and then consenting we will exclude patients who are more than 2 and a half years post-diagnosis at consent. 2. Unable to understand spoken/written English 3. ECOG status > 3 4. Diagnosed cognitive impairment (e.g. dementia) 5. Cognitive and/or physical impairment that prevents participation in brisk walking 6. Those who have a current diagnosis of metastatic disease 7. Due to have surgery to remove cancer in the next 5 months 8. < 6 weeks after surgery to remove cancer at consent 9. Reports achieving 150 minutes of at least moderate intensity PA weekly [80] 10. Report previous/current use of the study app app 11. Current participation in a health behaviour change study 12. Live with someone already participating in the trial 13. Incarcerated (i.e. address is a prison) 14. Already participated in the APPROACH pilot study (only applies at the pilot hospital site)
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Daily average minutes of brisk walking (=100 steps per minute) measured using an objective measure (an activPAL accelerometer), worn for 7 days at baseline, 3 and 6 months | — |
Secondary
| Measure | Time frame |
|---|---|
| 1. Average total steps, minutes of light physical activity, standing time and sitting time measured using an activPAL accelerometer at baseline, 3 and 6 months 2. Body Mass Index (BMI) self-reported using scales provided by the study at baseline, 3 and 6 months 3. Waist circumference self-reported using tape measure provided by the study at baseline, 3 and 6 months 4. Self-reported physical activity measured using the Godin Leisure Time Exercise Questionnaire (GLTEQ) at baseline, 3 and 6 months 5. Self-reported health status (using the five-level EuroQol-5D questionnaire,EQ-5D-5L), cancer-specific quality of life (using the Functional Assessment of Cancer Therapy-general, FACT-G), fatigue (FACT-F), sleep quality (Pittsburgh Sleep Quality Index, PSQI), anxiety (Generalised Anxiety Disorder Assessment, GAD-7), depression (Patient Health Questionnaire, PHQ-9), social support (brief form of the Perceived Social Support Questionnaire, F-Soz-UK-6), self-efficacy to manage cancer (Cancer Survivorship Self-Efficacy Scale, CS-SES) and physical activity self-efficacy (Physical Activity Appraisal Inventory, PAAI) at baseline, 3 and 6 months 6. Habit strength for walking measured using the Self-Report Behavioural Automaticity Index (SRBAI) at baseline, 3 and 6 months 7. App usage (in the intervention group) measured using questions from the Digital Behaviour Change Interventions Engagement Scale at 3 and 6 months 8. Health and social care service use measured using the Client Service Receipt Inventory (CSRI) at baseline, 3 and 6 months 9. Hospital service use measured using medical records over the 30 weeks after randomisation | — |
Countries
United Kingdom
Outcome results
None listed